M. Pietropaolo et al., ISLET-CELL AUTOANTIGEN 69-KD (ICA69) - MOLECULAR-CLONING AND CHARACTERIZATION OF A NOVEL DIABETES-ASSOCIATED AUTOANTIGEN, The Journal of clinical investigation, 92(1), 1993, pp. 359-371
We have identified a novel 69-kD peptide autoantigen (ICA69) associate
d with insulin-dependent diabetes mellitus (IDDM) by screening a human
islet lambdagt11 cDNA expression library with cytoplasmic islet cell
antibody positive sera from relatives of IDDM patients who progressed
to the overt disease. The deduced open reading frame of the ICA69 cDNA
predicts a 483-amino acid protein. ICA69 shows no nucleotide or amino
acid sequence relation to any known sequence in GenBank, except for t
wo short regions of similarity with BSA. The ICA69 cDNA probe hybridiz
es with a 2-kb mRNA in poly(A+ ) RNA from human pancreas, brain, heart
, thyroid, and kidney, but not with skeletal muscle, placenta, spleen,
or ovary. Expression of ICA69 was also detected in beta cells and cel
l lines, as well as in tumoral tissue of islet cell origin. The native
ICA69 molecule migrates to 69 kD in SDS-PAGE as detected with specifi
c antibodies. Serum samples from relatives of IDDM patients specifical
ly reacted with affinity-purified recombinant ICA69 on Western blottin
g. The structural gene for ICA69 was designated ICA]. A homologue in t
he mouse, designated Ica-1 was mapped to the proximal end of chromosom
e 6 (within 6 cM of the Met protooncogene). ICA69 adds a novel autoant
igen to the family of identified islet target molecules. and by the ma
nner of its identification and characterization large amounts of antig
en are available for development of quantitative, convenient predictiv
e assays for autoantibodies and analysis of the role of this molecule
in diabetes autoimmunity, as well as its physiologic function.